AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 276: R935-R942, 1999;
0363-6119/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokoyama, O.
Right arrow Articles by de Groat, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokoyama, O.
Right arrow Articles by de Groat, W. C.
Vol. 276, Issue 4, R935-R942, April 1999

Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion

Osamu Yokoyama1,2, Mitsuharu Yoshiyama1, Mikio Namiki2, and William C. de Groat1

1 Department of Pharmacology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; and 2 Department of Urology, Kanazawa University School of Medicine, Kanazawa, Ishikawa 920-8641, Japan

The contribution of glutamatergic and dopaminergic mechanisms to bladder hyperactivity after left middle cerebral artery occlusion was evaluated by determining the effects of intravenous cumulative doses of an N-methyl-D-aspartate (NMDA) glutamatergic antagonist (MK-801) and D1-selective (Sch-23390), D2-selective (sulpiride), or nonselective (haloperidol) dopaminergic antagonists on bladder activity in sham-operated (SO) and cerebral-infarcted (CI) rats. MK-801 (1 and 10 mg/kg) or sulpiride (3-30 mg/kg) significantly increased bladder capacity (BC) in CI but decreased or had no effect, respectively, on BC in SO. Sch-23390 (0.1-3 mg/kg) decreased BC in both SO and CI. In both CI and SO, low doses of haloperidol (0.1-1 mg/kg) increased BC, but a higher dose (3 mg/kg) reversed this effect. Administration of haloperidol (0.3 mg/kg) or sulpiride (10 mg/kg) in combination with MK-801 (0.01-10 mg/kg) markedly increased BC in CI but produced small decreases or increases in BC depending on the dose of MK-801 in SO. These results indicate that the bladder hyperactivity induced by cerebral infarction is mediated in part by NMDA glutamatergic and D2 dopaminergic excitatory mechanisms.

brain ischemia; micturition reflex; glutamate; MK-801; dopamine


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S.-F. Pan, H.-Y. Peng, C.-C. Chen, M.-J. Chen, S.-D. Lee, C.-L. Cheng, J.-C. Shyu, J.-M. Liao, G.-D. Chen, and T.-B. Lin
Nicotine-activated descending facilitation on spinal NMDA-dependent reflex potentiation from pontine tegmentum in rats
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1195 - F1204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J.-M. Liao, C.-H. Yang, C.-L. Cheng, S.-F. Pan, M.-J. Chen, P.-C. Huang, G.-D. Chen, K.-C. Tung, H.-Y. Peng, and T.-B. Lin
Spinal glutamatergic NMDA-dependent cyclic pelvic nerve-to-external urethra sphincter reflex potentiation in anesthetized rats
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F790 - F800.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J.-M. Liao, P.-C. Huang, S.-F. Pan, M.-J. Chen, K.-C. Tung, H.-Y. Peng, J.-C. Shyu, Y.-M. Liou, G.-D. Chen, and T.-B. Lin
Spinal glutamatergic NMDA-dependent pelvic nerve-to-external urethra sphincter reflex potentiation caused by a mechanical stimulation in anesthetized rats
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1791 - F1801.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S.-J. Lee, Y. Nakamura, and W. C. de Groat
Effect of ({+/-})-epibatidine, a nicotinic agonist, on the central pathways controlling voiding function in the rat
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R84 - R90.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Kanie, O. Yokoyama, K. Komatsu, K. Kodama, S. Yotsuyanagi, S. Niikura, Y. Nagasaka, K.-I. Miyamoto, and M. Namiki
GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1230 - R1238.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Nakada, O. Yokoyama, K. Komatsu, K. Kodama, S. Yotsuyanagi, S. Niikura, Y. Nagasaka, and M. Namiki
Effects of Aniracetam on Bladder Overactivity in Rats with Cerebral Infarction
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 921 - 928.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online